LGBTQ activist and ex-UBS banker Scott Miller becomes US ambassador to Switzerland

The Senate has confirmed President Biden’s candidate for the post of American Ambassador to Switzerland and Liechtenstein.

Wann Scott Miller als US-Botschafter nach Bern kommt, ist noch unklar.

When Scott Miller will come to Bern as US ambassador is still unclear.

Matthew Staver / PD

mbe./(Reuters)

The new American ambassador in Bern is Scott Miller. The 41-year-old philanthropist and LGBTQ activist from Denver, Colorado was nominated by President Joe Biden in August and approved by the Senate on Saturday. He replaces Ed McMullen, who was appointed by former President Trump and served as US ambassador from fall 2017 to early 2021.

In addition to Miller, the Senate confirmed more than 50 other Biden candidates as new ambassadors for the United States around the world. Including the former mayor of Chicago, Rahm Emanuel, as ambassador to Japan. Emanuel, former White House chief of staff under President Barack Obama, lost support in his party in 2014 due to his handling of the police shots at the black teenager Lacquan McDonald.

Activist with a connection to Switzerland

Miller was one of Joe Biden’s supporters in the election campaign. He advised his campaign, organized fundraisers in Colorado and made donations for the Democrats himself. Hailing from conservative Colorado, Miller has made a name for himself as an advocate for the rights of lesbian, gay, bisexual, trans, and queer people (LGBTQ).

Miller also has references to Switzerland in his résumé. He worked as vice president of the wealth management division at the major UBS bank in Denver. In a statement following his nomination in August, he said that if the Senate confirmed, he wanted to consolidate the “already strong partnership that connects the Americans with the Swiss and Liechtensteiners, including the dynamic relationships in trade, investment and arms issues ».

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
'Stealth Omicron' spreads more than original strain: study thumbnail

‘Stealth Omicron’ spreads more than original strain: study

Credit: Pixabay/CC0 Public Domain A sub-variant of the highly contagious Omicron coronavirus strain is even more infectious than the original version, according to a Danish study published on Monday. Sub-variant BA.2—also called "stealth Omicron"—was detected earlier this year and has displaced the first Omicron variant, known as BA.1, as the dominant strain in Denmark. A…
Read More
The transformational power of AI for patient groups thumbnail

The transformational power of AI for patient groups

​​Since OpenAI’s official launch of ChatGPT, we have seen a sharp increase in the healthcare industry’s adoption of AI tools across different use cases, from improving diagnostic precision and personalising treatment plans to streamlining administrative processes. Several military hospitals in Asia have begun adopting AI solutions in diagnostics and teleconsulting services.  AI has the potential
Read More
Inert Ingredient Tied to Allergic Reactions to COVID-19 Vaccines thumbnail

Inert Ingredient Tied to Allergic Reactions to COVID-19 Vaccines

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A common inert ingredient may be the culprit behind the rare allergic reactions reported among individuals who have received mRNA COVID-19 vaccines, according to investigators at a large regional health center that was among the first to administer the shots. Blood…
Read More
The Broader Significance of a New Drug for a Rare Form of ALS thumbnail

The Broader Significance of a New Drug for a Rare Form of ALS

Opinion > Second Opinions — The tofersen trial offers hope and lessons for the fight against ALS by Jonathan D. Glass, MD May 15, 2023 A major milestone in the treatment of amyotrophic lateral sclerosis (ALS) occurred on April 25, 2023, when the FDA approved tofersen (Qalsody) for patients carrying the disease-causing mutation superoxide dismutase
Read More
Index Of News
Total
0
Share